Structure and Functions of Coagulation Factor IX/Factor X-Binding Protein Isolated from the Venom of Trimeresurus flavoviridis

  • Takashi Morita
  • Hideko Atoda
  • Fujio Sekiya
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 391)

Abstract

Snake venoms contain various anticoagulants that affect blood coagulation system (1, 2). The anticoagulant is classified into two categories: anticoagulant enzymes and non-enzymatic anticoagulants. The examples of the former category are phospholipases, fibrinogenolytic enzymes, protein C activators, and proteolytic enzymes that convert coagulation factors into degraded inactive forms. An interesting example of the non-enzymatic anticoagulants is an inhibitor of the activation of prothrombin. The inhibitors in this category have been first found in the venom of Agkistrodon acutus (3) and Trimeresurus gramineus (4). The anticoagulant protein isolated from A. acutus inhibits the participation of factor Xa in the prothrombinase complex formation (5, 6). In order to understand the anticoagulant mechanism we have isolated and characterized another anticoagulant protein with Mr 27,000 from the venom of the habu snake Trimeresurus flavoviridis (7). This anticoagulant protein forms a complex with either coagulation factor IX or factor X with a stoichiometry of 1 to 1 in a calcium-dependent fashion, and thereby blocks the amplification of the coagulation cascade (7). Thus, we named it IX/X-bp (factor IX/factor X-binding protein). This chapter describes the structural and functional properties of IX/X-bp from the venom of the habu snake (T. flavoviridis).

Keywords

Snake Venom Blood Coagulation Factor Anticoagulant Protein Pancreatic Stone Protein Serine Protease Domain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tu, A. T., 1977, Venom: Chemistry and Molecular Biology, John Wiley and Sons, New York.Google Scholar
  2. 2.
    Pirkle, H., and Markland, F. S. Jr., 1987, Hemostasis and Animal Venoms, Marcel Dekker, New York.Google Scholar
  3. 3.
    Ouyang, C, and Teng, C.-M., 1972, Purification and properties of the anticoagulant principle of Agkistrodon acutus venom, Biochim. Biophys. Acta 278: 155–162.Google Scholar
  4. 4.
    Ouyang, C, and Yang, F.-Y, 1975, Purification and properties of the anticoagulant principle of Trimere-surus gramineus venom, Biochim. Biophys. Acta 386: 479–492.Google Scholar
  5. 5.
    Ouyang, C, and Teng, C.-M., 1973, The effect of the purified anticoagulant principle of Agkistrodon acutus venom on blood coagulation, Toxicon 11: 287–292.PubMedCrossRefGoogle Scholar
  6. 6.
    Teng, C. -M., and Seegers, W. H., 1981, Agkistrodon acutus snake venom inhibits prothrombinase complex formation. Thromb. Res. 23: 255–263.Google Scholar
  7. 7.
    Atoda, H., and Morita, T, 1989, A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (habu snake)isolation and characterization, J. Biochem. (Tokyo) 106: 808–813.Google Scholar
  8. 8.
    Atoda, H., Hyuga, M., and Morita, T, 1991, The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycopro-tein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E, J. Biol. Chem. 266: 14903–14911.PubMedGoogle Scholar
  9. 9.
    Atoda, H., and Morita, T., 1993, Arrangement of the disulfide bridges in a blood coagulation factor IX/factor X-binding protein from the venom of Trimeresurus flavoviridis, J. Biochem. (Tokyo) 113: 159–163.Google Scholar
  10. 10.
    Rouimi, P., De Caro, J., Bonicel, J., Rovery, M., and De Caro, A., 1988, The disulfide bridges of the immunoreactive forms of human pancreatic stone protein isolated from pancreatic juice, FEBS Lett. 229: 171–174.PubMedCrossRefGoogle Scholar
  11. 11.
    Muramoto, K., and Kamiya, H., 1990, The positions of the disulfide bonds and glycosylation site in a lectin of the acorn barnacle Megabalanus rosa, Biochim. Biophys. Acta 1039: 52–60.Google Scholar
  12. 12.
    Giga, Y., Ikai, A., and Takahashi, K., 1987, The complete amino acid sequence of echinoidin, a lectin from the coelomic fluid of the sea urchin Anthocidaris crassispina, J. Biol Chem. 262: 6197–6203.PubMedGoogle Scholar
  13. 13.
    Hirabayashi, J., Kusunoki, T., and Kasai, K., 1991, Complete primary structure of a galactose-specific lectin from the venom of rattlesnake Crotalus atrox. J. Biol Chem. 266: 2320–2326.PubMedGoogle Scholar
  14. 14.
    Sandy, J. D., Flannery, C. R., Boynton, R. E., and Neame, P. J., 1990, Isolation and characterization of disulfide-bonded peptides from the three globular domains of aggregating cartilage proteoglycan, J. Biol Chem. 265: 21108–21113.PubMedGoogle Scholar
  15. 15.
    Fuhlendorff, J., Clemmensen, I., and Magnusson, S., 1987, Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: Homology with asialoglycoprotein receptors and cartilage proteoglycan core protein, Biochemistry 26: 6757–6764.PubMedCrossRefGoogle Scholar
  16. 16.
    Drickamer, K., 1993, Evolution of Ca2+-dependent animal lectins. Prog. Nucleic Acid Res. and Mol. Biol, 45: 207–232.CrossRefGoogle Scholar
  17. 17.
    Mizuno, H., Atoda, H., and Morita, T., 1991, Crystallization and preliminary X-ray study of blood coagulation factor IX/factor X-binding protein with anticoagulant activity from habu snake venom, J. Mol. Biol. 220: 225–226.PubMedCrossRefGoogle Scholar
  18. 18.
    Atoda, H., Yoshida, N., Ishikawa, M., and Morita, T., 1994, Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis, Eur. J. Biochem. 224: 703–708.PubMedCrossRefGoogle Scholar
  19. 19.
    Ohsawa, K., Kimura, M., Kurosawa-Ohsawa, K., Takahashi, M., Koyama, M., Abiko, Y., Hirahara, K., Matsuishi, T., and Tanaka, S., 1988, Purification of sufficiently gamma-carboxylated recombinant protein C and its derivatives. Calcium-dependent affinity shift in immunoaffinity and ion exchange chromatography, J. Chromatography 597: 285–291.CrossRefGoogle Scholar
  20. 20.
    Morita, T., and Atoda, H., 1993, The structural characterization of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis, Currents Aspects of Blood Coagulation, Fibrinolysis, and Platelets (Shen, M.-C, Teng, C.-M., and Takada, A. eds.) pp.35–40, Springer-Verlag, Tokyo.Google Scholar
  21. 21.
    Sekiya, F., Atoda, H., and Morita, T., 1993, Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca, Biochemistry 32: 6892–6897.PubMedCrossRefGoogle Scholar
  22. 22.
    Usami, Y., Fujimura, Y., Suzuki, M., Ozeki, Y., Nishio, K., Fukui, H., and Titani, K., 1993, Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca, Proc. Natl. Acad. Sci. USA 90: 928–932.PubMedCrossRefGoogle Scholar
  23. 23.
    Fujimura, Y., Titani, K., Usami, Y., Suzuki, M., Oyama, T., Matsui, T., Fukui, H., Sugimoto, M., and Ruggeri, Z. M., 1991, Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca, Biochemistry 30: 1957–1964.PubMedCrossRefGoogle Scholar
  24. 24.
    Zingali, R. B., Jandrot-Perrus, M., Guillin, M.-C, and Bon, C, 1993, Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: Characterization and mechanism of thrombin inhibition, Biochemistry 32: 10794–10802.PubMedCrossRefGoogle Scholar
  25. 25.
    Takeya, H., Nishida, S., Miyata, T., Kawada, S., Saisaka, Y., Morita, T., and Iwanaga, S., 1992, Coagulation factor X activating enzyme from Russell’s viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains, J. Biol Chem. 267: 14109–14117.PubMedGoogle Scholar
  26. 26.
    Peng, M., Lu, W., and Kirby, E. P., 1991, Alboaggregin-B: A new platelet agonist that binds to platelet membrane glycoprotein lb, Biochemistry 30: 11529–11536.PubMedCrossRefGoogle Scholar
  27. 27.
    Yoshida, E., Fujimura, Y., Miura, S., Sugimoto, M., Fukui, H., Narita, N., Usami, Y., Suzuki, M., and Titani, K., 1993, Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelet, Biochem. Biophys. Res. Commun. 191: 1386–1392.Google Scholar
  28. 28.
    Peng, M., Lu, W., Beviglia, L.,Niewiarowski, S., and Kirby, E. P., 1993, Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein lb, Blood 81: 2321–2328.PubMedGoogle Scholar
  29. 29.
    Peng, M., Holt, J. C, and Niewiarowski, S., 1994, Isolation, characterization and amino acid sequence of echicetin beta-subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein lb, Biochem. Biophys. Res. Commun. 205: 68–72.Google Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Takashi Morita
    • 1
  • Hideko Atoda
    • 1
  • Fujio Sekiya
    • 1
  1. 1.Department of BiochemistryMeiji College of PharmacyTanashi, TokyoJapan

Personalised recommendations